These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1261101

  • 1. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P, Roels L, Vanrenterghem Y, Boel A, van Damme B, Vermylen J.
    Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
    [Abstract] [Full Text] [Related]

  • 2. [Significance of fibrinuria for the evolution of treated glomerulonephritis].
    Michielsen P, Roels L, Vanrenterghem Y, Boel A, Van Damme B, Vermylen J.
    J Urol Nephrol (Paris); 1975 Mar; 81(4-5):269-80. PubMed ID: 1159886
    [No Abstract] [Full Text] [Related]

  • 3. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T, Sumie A, Ishii T, Tomo T, Magari Y, Sato J, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [Abstract] [Full Text] [Related]

  • 4. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
    Bouissou F, Barthe P, Boneu B.
    Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
    [Abstract] [Full Text] [Related]

  • 5. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD, Terry JM.
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [Abstract] [Full Text] [Related]

  • 6. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T, Magari Y, Mizunaga S, Okabe E, Sumie A, Ishii T, Tomo T, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [Abstract] [Full Text] [Related]

  • 7. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP.
    N Z Med J; 1977 Oct 12; 86(597):332-4. PubMed ID: 272538
    [Abstract] [Full Text] [Related]

  • 8. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M, Oetliker O, Montandon A, Beck EA.
    Schweiz Med Wochenschr; 1975 Aug 16; 105(33):1040-7. PubMed ID: 1099647
    [Abstract] [Full Text] [Related]

  • 9. [Urinary cross-linked FDP in various renal diseases].
    Inuma H.
    Nihon Jinzo Gakkai Shi; 1994 Feb 16; 36(2):146-57. PubMed ID: 8139147
    [Abstract] [Full Text] [Related]

  • 10. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007 Feb 16; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M.
    Clin Nephrol; 1995 Aug 16; 44(2):91-5. PubMed ID: 8529315
    [Abstract] [Full Text] [Related]

  • 13. Urinary cross-linked fibrin degradation products in glomerular disease with crescents.
    Kamitsuji H, Matsunaga K, Taira K, Nakajima M, Whitworth JA, Kincaid-Smith P.
    Clin Nephrol; 1988 Mar 16; 29(3):124-8. PubMed ID: 3359703
    [Abstract] [Full Text] [Related]

  • 14. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL, Francis CW, Knutson DW, Marder VJ.
    J Lab Clin Med; 1986 Jun 16; 107(6):534-43. PubMed ID: 3519810
    [Abstract] [Full Text] [Related]

  • 15. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E, Seyfarth M, Templin R, Schneider P, Klinkmann H.
    Proc Eur Dial Transplant Assoc; 1978 Jun 16; 15():466-72. PubMed ID: 368788
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic glomerulonephritis using indomethacin and small doses of cyclophosphamide].
    Vanrenteghem Y, Roels L, Verberckmoes R, Michielsen P.
    J Urol Nephrol (Paris); 1975 Jun 16; 81(4-5):281-90. PubMed ID: 1159887
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K, Ito Y, Uriu K, Eto S.
    Nihon Jinzo Gakkai Shi; 1993 Jan 16; 35(1):29-34. PubMed ID: 8336397
    [Abstract] [Full Text] [Related]

  • 18. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC, Hockley M, Fenton SS, Wilson DR.
    Clin Nephrol; 1977 Jun 16; 7(6):255-61. PubMed ID: 326454
    [Abstract] [Full Text] [Related]

  • 19. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K, Nagase M, Takada Y, Takada A.
    Thromb Res; 1987 Feb 15; 45(4):403-11. PubMed ID: 3576523
    [Abstract] [Full Text] [Related]

  • 20. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
    Bone JM, Sherman LA, Valdes AJ, Lubowitz H.
    J Lab Clin Med; 1977 May 15; 89(5):1043-52. PubMed ID: 558266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.